Caroline Litchfield
Direttore Finanziario/CFO presso IMMUNE DESIGN CORP
Patrimonio netto: - $ in data 30/04/2024
Profilo
La signora Caroline A. Litchfield è direttore finanziario e amministratore della Immune Design Corp. e direttore finanziario e vicepresidente esecutivo della Merck & Co. Fa parte del Consiglio di amministrazione di Immune Design Corp. La signora Litchfield è stata precedentemente impiegata come direttore finanziario presso Merck Sharp & Dohme Ltd. Si è laureata presso l'Università di Leicester.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
MERCK & CO., INC.
-.--% | 30/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Caroline Litchfield
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNE DESIGN CORP | Direttore Finanziario/CFO | - |
| MERCK & CO., INC. | Direttore Finanziario/CFO | 01/04/2021 |
Precedenti posizioni note di Caroline Litchfield
| Società | Posizione | Fine |
|---|---|---|
| ORGANON & CO. | Direttore/Membro del Consiglio | 31/05/2021 |
| FULFORD (INDIA) LIMITED | Direttore/Membro del Consiglio | 30/01/2014 |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Direttore Finanziario/CFO | 23/06/2009 |
Formazione di Caroline Litchfield
| University of Leicester | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Aziende private | 3 |
|---|---|
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Fulford (India) Ltd.
 Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India. | Health Technology |
- Borsa valori
- Insiders
- Caroline Litchfield
